CONCENTRATES

NaturaLyte Liquid Acid Concentrate

Fresenius Renal Technologies is a leading supplier of hemodialysis concentrates. For over 20 years, we have offered a complete range of acid concentrates designed for customers and patients. Access the latest innovations in dialysate, including traditional acetic-based concentrates.

ASK ABOUT LIQUID ACID CONCENTRATES GET SUPPORT INDICATIONS, SAFETY AND WARNINGS

NaturaLyte® Liquid Acid Concentrate (Cases and Drums)

Our oldest acid concentrate, NaturaLyte® liquid acid concentrate, with the widest variety of formulations in the industry today, has been prescribed and utilized by healthcare professionals for over 20 years.

Dissolution Systems

Available in jugs (0.905 gallons or 3.43 liters), 4 jugs per case, and 55-gallon drums with a 45X mix ratio, this concentrate is formulated to be used in conjunction with sodium bicarbonate concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine. For every 45 volume parts of dialysate: 1 volume part of the NaturaLyte acid concentrate, 1.72 volume parts of sodium bicarbonate concentrate and 42.28 volume parts of Purified Water (AAMI quality) are used.

NaturaLyte® — 4000 Series Acid Concentrate Formulations

RESOURCES

RELATED PRODUCTS

 

Caution: Federal (US) law restricts these devices to sale by or on the order of a physician.

Note: Read the Instructions for Use for safe and proper use of these devices. For a complete description of hazards, contraindications, side effects and precautions, see full package labeling.

© 2011-2019, Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Fresenius Renal Technologies, 2008, BlueStar, 2008K@home, GranuFlo, NaturaLyte and bibag are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. Citrasate is a registered trademark of Advanced Renal Technologies, Inc. in the United States and is used under license. All other trademarks are the property of their respective owners. P/N 101345-01 Rev D 11/2019